Ipsen, a leading pharmaceutical company, develops a range of innovative neuromodulators used in various medical applications. Among their notable offerings are Decapeptyl, Dysport, and Bocouture, each contributing a unique role in addressing specific myostatin inhibitor clinical needs. Decapeptyl, a potent gonadotropin-releasing hormone agonist, i